Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
20 June 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Ranmark Articles
Sales of cancer pain therapies set to grow to $5.2 billion in the G7 by 2021
13 December 2012
Daiichi Sankyo debuts bone cancer drug Ranmark in Japan
17 April 2012
Japanese approval for Regnite and Ranmark
18 January 2012
Showing 1-3 of 3 articles
1
Hot Topics
Most Read
Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
US Supreme Court says patent settlement can "sometimes" be illegal
Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
Australia's pharma industry applauds R&D regulatory reform
Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
US Supreme Court says patent settlement can "sometimes" be illegal
Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
Australia's pharma industry applauds R&D regulatory reform